Role of cAMP and phosphodiesterase signaling in liver health and disease

Resveratrol improves health and survival of mice on a high-calorie diet

Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · see citing works

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,067 · see citing works

Mechanisms of hepatic stellate cell activation

Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · see citing works

Seven-transmembrane receptors

Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712 · see citing works

Mechanisms of Hepatic Fibrogenesis

Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,640 · see citing works

Transcriptional regulation by the phosphorylation-dependent factor CREB

Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587 · see citing works

CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals

Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,135 · see citing works

Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury

Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,090 · see citing works

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

de Rooij, J., Zwartkruis, F. J. T., Verheijen, M. H. G., Cool, R. H., Nijman, S. M. B., Wittinghofer, A., & Bos, J. L. (1998) · Nature · doi:10.1038/24884 · Cited by 1,970 · see citing works

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · see citing works

Hepatic stellate cells as key target in liver fibrosis

Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · see citing works

An Adenosine 3′,5′-Monophosphate-dependant Protein Kinase from Rabbit Skeletal Muscle

Walsh, D. A., Perkins, J. P., & Krebs, E. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34204-8 · Cited by 1,448 · see citing works

CREB regulates hepatic gluconeogenesis through the coactivator PGC-1

Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440 · see citing works

A Family of cAMP-Binding Proteins That Directly Activate Rap1

Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E., & Graybiel, A. M. (1998) · Science · doi:10.1126/science.282.5397.2275 · Cited by 1,360 · see citing works

Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases

Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,352 · see citing works

Liver inflammation and fibrosis

Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295 · see citing works

Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling

Conti, M., & Beavo, J. A. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.150444 · Cited by 1,188 · see citing works

cAMP-DEPENDENT PROTEIN KINASE: FRAMEWORK FOR A DIVERSE FAMILY OF REGULATORY ENZYMES

Taylor, S. S., Buechler, J. A., & Yonemoto, W. M. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004543 · Cited by 1,144 · see citing works

Cyclic Nucleotide-Gated Ion Channels

Kaupp, U. B., & Seifert, R. (2002) · Physiological Reviews · doi:10.1152/physrev.00008.2002 · Cited by 1,141 · see citing works

FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES

Sutherland, E. W., & Rall, T. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77423-7 · Cited by 1,080 · see citing works

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Boolell, M., Mj, A., Sa, B., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., Ih, O., & Gingell, C. (1996) · PubMed · Cited by 1,067 · see citing works

Structure of a Peptide Inhibitor Bound to the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

Knighton, D. R., Zheng, J., Eyck, L. F. T., Xuong, N., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862343 · Cited by 960 · see citing works

Cyclic AMP

Robinson, G. A., Butcher, R. W., & Sutherland, E. W. (1968) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.37.070168.001053 · Cited by 958 · see citing works

Triggering and resolution of inflammation in NASH

Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943 · see citing works

Cyclic nucleotide research — still expanding after half a century

Beavo, J. A., & Brunton, L. L. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm911 · Cited by 906 · see citing works

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

Calverley, P. M. A., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martínez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 821 · see citing works

A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK

Enserink, J. M., Christensen, A. E., de Rooij, J., van Triest, M. H., Schwede, F., Genieser, H., Døskeland, S. O., Blank, J. L., & Bos, J. L. (2002) · Nature Cell Biology · doi:10.1038/ncb874 · Cited by 704 · see citing works

Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice

Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 699 · see citing works

Cooperation of Liver Cells in Health and Disease

Kmieć, Z. (2001) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-56553-3 · Cited by 631 · see citing works

Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease

Llopis, M., Cassard, A., Wrzosek, L., Boschat, L., Bruneau, A., Ferrere, G., Puchois, V., Martin, J., Lepage, P., Roy, T. L., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310585 · Cited by 562 · see citing works

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

Ding, X., Saxena, N. K., Lin, S., Gupta, N., & Anania, F. A. (2006) · Hepatology · doi:10.1002/hep.21006 · Cited by 557 · see citing works

Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients

Khoruts, A., Stahnke, L., McClain, C. J., Logan, G., & Allen, J. I. (1991) · Hepatology · doi:10.1002/hep.1840130211 · Cited by 549 · see citing works

Mechanisms of Fibrogenesis

Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 507 · see citing works

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

Iimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H., & Thurman, R. G. (1997) · Hepatology · doi:10.1002/hep.510260621 · Cited by 496 · see citing works

Matrix metalloproteinases in liver injury, repair and fibrosis

Duarte, S. M., Baber, J. T., Fujii, T., & Coito, A. J. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.004 · Cited by 481 · see citing works

Increased Plasma Tumor Necrosis Factor in Severe Alcoholic Hepatitis

Bird, G. L. A., Sheron, N., Goka, A. K. J., Alexander, G., & Williams, R. L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-917 · Cited by 457 · see citing works

STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease

Petrasek, J., Iracheta‐Vellve, A., Csák, T., Satishchandran, A., Kodys, K., Kurt‐Jones, E. A., Fitzgerald, K. A., & Szabó, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308331110 · Cited by 449 · see citing works

Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory

Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H. M., & Kandel, E. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15020 · Cited by 431 · see citing works

Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown

Houslay, M. D. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.007 · Cited by 431 · see citing works

Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes

Joshi‐Barve, S., Barve, S. S., Amancherla, K., Gobejishvili, L., Hill, D. B., Cave, M. C., Hote, P., & McClain, C. J. (2007) · Hepatology · doi:10.1002/hep.21752 · Cited by 406 · see citing works

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

Svegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405 · see citing works

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

Rivera, L., Morón, R., Zarzuelo, A., & Galisteo, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.027 · Cited by 391 · see citing works

Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses

Jin, S.-L. C., & Conti, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122041599 · Cited by 368 · see citing works

Epac and PKA: a tale of two intracellular cAMP receptors

Cheng, X., Ji, Z., Tsalkova, T. N., & Mei, F. C. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00438.x · Cited by 358 · see citing works

Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management

Olin, J. W., & Sealove, B. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0133 · Cited by 349 · see citing works

Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells

Ollivier, V., Parry, G. C., Cobb, R. R., de Prost, D., & Mackman, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20828 · Cited by 333 · see citing works

CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ

Herzig, S., Hedrick, S. A., Morantte, I. G., Koo, S., Galimi, F., & Montminy, M. (2003) · Nature · doi:10.1038/nature02110 · Cited by 321 · see citing works

PKA: a portrait of protein kinase dynamics

Taylor, S. S., Yang, J., Wu, J., Haste, N. M., Radzio-Andzelm, E., & Anand, G. S. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.029 · Cited by 318 · see citing works

Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease

Ashraf, N. U., & Sheikh, T. A. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1078461 · Cited by 311 · see citing works

Plasma Tumor Necrosis Factor α Predicts Decreased Long‐Term Survival in Severe Alcoholic Hepatitis

Felver, M. E., Mezey, E., McGuire, M., Mitchell, M. C., Herlong, H. F., Veech, G. A., & Veech, R. L. (1990) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1990.tb00482.x · Cited by 293 · see citing works

The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury

Hannila, S. S., & Filbin, M. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.020 · Cited by 289 · see citing works

A concise review of non-alcoholic fatty liver disease

Than, N. N., & Newsome, P. N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.001 · Cited by 289 · see citing works

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

SHANG, J., CHEN, L.-L., XIAO, F.-X., SUN, H., DING, H.-C., & XIAO, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00807.x · Cited by 274 · see citing works

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

García‐Osta, A., Cuadrado‐Tejedor, M., García, C., Oyarzábal, J., & Franco, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000907 · Cited by 260 · see citing works

Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages

Jin, S.-L. C., Lan, L., Zoudilova, M., & Conti, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1523 · Cited by 256 · see citing works

Non Alcoholic Fatty Liver: Epidemiology and Natural History

Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., & Persico, M. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216111143 · Cited by 247 · see citing works

cAMP regulation of airway smooth muscle function

Billington, C. K., Ojo, O. O., Penn, R. B., & Ito, S. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.05.007 · Cited by 242 · see citing works

Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development

Jeon, Y. H., Heo, Y. S., Kim, C. M., Hyun, Y.-L., Lee, T. G., Ro, S., & Cho, J. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4533-5 · Cited by 234 · see citing works

Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver

Peluso, M. R. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100802 · Cited by 218 · see citing works

The Antidepressant and Antiinflammatory Effects of Rolipram in the Central Nervous System

Zhu, J., Mix, E., & Winblad, B. G. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00206.x · Cited by 216 · see citing works

The Role of Cyclic AMP in the Control of Carbohydrate Metabolism

Sutherland, E. W., & Robison, G. A. (1969) · Diabetes · doi:10.2337/diab.18.12.797 · Cited by 215 · see citing works

Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis

Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211 · see citing works

CYP2E1-dependent toxicity and oxidative stress in HepG2 cells,

Cederbaum, A. I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00743-2 · Cited by 210 · see citing works

Cilostazol for intermittent claudication

Bedenis, R., Stewart, M. C. W., Cleanthis, M., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003748.pub4 · Cited by 200 · see citing works

Update on the therapeutic potential of PDE4 inhibitors

Montana, J. G., & Dyke, H. J. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.1.1 · Cited by 197 · see citing works

Structure, mechanism, and regulation of soluble adenylyl cyclases — similarities and differences to transmembrane adenylyl cyclases

Steegborn, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.012 · Cited by 196 · see citing works

Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis

Jitrapakdee, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 189 · see citing works

Dancing with Different Partners: Protein Kinase A Phosphorylation of Seven Membrane-Spanning Receptors Regulates Their G Protein-Coupling Specificity

Lefkowitz, R. J., Pierce, K. L., & Luttrell, L. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.971 · Cited by 180 · see citing works

Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells

Conti, M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.9.0534 · Cited by 178 · see citing works

cAMP and Epac in the regulation of tissue fibrosis

Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175 · see citing works

Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway

Zhang, Y., Chen, M., Zhou, Y., Yi, L., Gao, Y., Ran, L., Chen, S., Zhang, T., Zhou, X., Zou, D., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500016 · Cited by 170 · see citing works

Anti-fibrogenic strategies and the regression of fibrosis

Kisseleva, T., & Brenner, D. A. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.011 · Cited by 169 · see citing works

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

Li, J., Liao, Z., Ping, J., Xu, D., & Wang, H. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2180-y · Cited by 167 · see citing works

Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients.

Diamond, I., WRUBEL, B., Estrin, W. J., & Gordon, A. S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1413 · Cited by 164 · see citing works

Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver

Tian, Y., Ma, J., Wang, W., Zhang, L., Xu, J., Wang, K., & Li, D. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2807-x · Cited by 161 · see citing works

Activation of the Innate Immune System and Alcoholic Liver Disease: Effects of Ethanol per se or Enhanced Intestinal Translocation of Bacterial Toxins Induced by Ethanol?

Bode, C., & Bode, J. C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189280.19073.28 · Cited by 158 · see citing works

Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies

Bravi, F., Tavani, A., Bosetti, C., Boffetta, P., & Vecchia, C. L. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000252 · Cited by 151 · see citing works

The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)

Louet, J., Hayhurst, G. P., Gonzalez, F. J., Girard, J. R., & Decaux, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205087200 · Cited by 150 · see citing works

Pathogenesis, Diagnosis, and Treatment of Alcoholic Liver Disease

Menon, K. V., Gores, G. J., & Shah, V. H. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.10.1021 · Cited by 149 · see citing works

Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate

Kleinboelting, S., Diaz, A., Moniot, S., van den Heuvel, J., Weyand, M., Levin, L. R., Buck, J., & Steegborn, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322778111 · Cited by 140 · see citing works

Role of the cAMP Pathway in Glucose and Lipid Metabolism

Ravnskjær, K., Madiraju, A. K., & Montminy, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_32 · Cited by 140 · see citing works

Toll-Like Receptor Signaling and Liver Fibrosis

Aoyama, T., Paik, Y., & Seki, E. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/192543 · Cited by 139 · see citing works

The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?

Sapio, L., Gallo, M., Illiano, M., Chiosi, E., Naviglio, D., Spina, A., & Naviglio, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25650 · Cited by 138 · see citing works

Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis

Lebrec, D., Thabut, D., Oberti, F., Perarnau, J., Condat, B., Barraud, H., Saliba, F., Carbonell, N., Renard, P., Ramond, M.-J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.040 · Cited by 136 · see citing works

Selective Cyclic Nucleotide Phosphodiesterase Inhibitors as Potential Therapeutic Agents

Weiss, B., & Hait, W. N. (1977) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.17.040177.002301 · Cited by 135 · see citing works

Systematic review with meta‐analysis: coffee consumption and the risk of cirrhosis

Kennedy, O. J., Roderick, P. J., Buchanan, R. M., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13523 · Cited by 126 · see citing works

A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids

Giembycz, M. A., Kaur, M., Leigh, R., & Newton, R. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707627 · Cited by 124 · see citing works

New Dietary Supplements for Obesity: What We Currently Know

Ríos-Hoyo, A., & Gutiérrez-Salmeán, G. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0214-y · Cited by 122 · see citing works

Phosphodiesterase 4-targeted treatments for autoimmune diseases

Kumar, N., Goldminz, A. M., Kim, N., & Gottlieb, A. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-96 · Cited by 121 · see citing works

CO2/HCO3−- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor

Zippin, J. H., Chen, Y., Straub, S. G., Hess, K. C., Diaz, A., Lee, D., Tso, P., Holz, G. G., Sharp, G. W. G., Levin, L. R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510073 · Cited by 116 · see citing works

cAMP enhances insulin secretion by an action on the ATP-sensitive K+ channel-independent pathway of glucose signaling in rat pancreatic islets.

Yajima, H., Komatsu, M., Schermerhorn, T., Aizawa, T., Kaneko, T., Nagai, M., Sharp, G. W. G., & Hashizume, K. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1006 · Cited by 110 · see citing works

Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition

Xu, Z., Huo, J., Ding, X., Yang, M., Li, L., Dai, J., Hosoe, K., Kubo, H., Mori, M., Higuchi, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08899-7 · Cited by 108 · see citing works

Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet

Alberdi, G., Rodríguez, V. M., Macarulla, M. T., Miranda, J., Churruca, I., & Portillo, M. P. (2012) · Nutrition · doi:10.1016/j.nut.2012.09.011 · Cited by 106 · see citing works

Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus

Wouters, E. F. �., Bredenbröker, D., Teichmann, P., Brose, M., Rabe, K. F., Fabbri, L. M., & Göke, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2886 · Cited by 106 · see citing works

Gut microbiome and liver disease

Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 104 · see citing works

Recent trends in the epidemiology of alcoholic liver disease

Singal, A. K., & Anand, B. S. (2013) · Clinical Liver Disease · doi:10.1002/cld.168 · Cited by 103 · see citing works

Dual PDE 3/4 and PDE 4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases

Abbott-Banner, K., & Page, C. P. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12209 · Cited by 99 · see citing works

IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury

Arai, T., Hiromatsu, K., Kobayashi, N., Takano, M., Ishida, H., Nimura, Y., & Yoshikai, Y. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5743 · Cited by 96 · see citing works

GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis

López-Sánchez, I., Dunkel, Y., Roh, Y., Mittal, Y., Minicis, S. D., Murányi, A., Singh, S., Shanmugam, K., Aroonsakool, N., Murray, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms5451 · Cited by 92 · see citing works

Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-κB activity and TNF expression: relevance to alcoholic liver disease

Gobejishvili, L., Barve, S. S., Joshi‐Barve, S., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2006 · Cited by 88 · see citing works

Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133.

Houglum, K., Lee, K. S., & Chojkier, M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119291 · Cited by 84 · see citing works

Coffee and Liver Disease

Wadhawan, M., & Anand, A. C. (2016) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2016.02.003 · Cited by 83 · see citing works

Treating COPD with PDE 4 inhibitors.

Brown, W. M. (2007) · PubMed Central · Cited by 78 · see citing works

Relation of Endotoxin, Endotoxin Binding Proteins and Macrophages to Severe Alcoholic Liver Injury and Multiple Organ Failure

Fukui, H. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189278.30237.e9 · Cited by 76 · see citing works

Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease

Gobejishvili, L., Barve, S. S., Joshi‐Barve, S., & McClain, C. J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90232.2008 · Cited by 76 · see citing works

Forskolin, a hedgehog signalling inhibitor, attenuates carbon tetrachloride‐induced liver fibrosis in rats

El-Agroudy, N. N., El‐Naga, R. N., El‐Razeq, R. A., & El‐Demerdash, E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13611 · Cited by 76 · see citing works

β-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure

Schott, M. B., Rasineni, K., Weller, S. G., Schulze, R. J., Sletten, A. C., Casey, C. A., & McNiven, M. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777748 · Cited by 76 · see citing works

Phosphorylation of Serine 11 and Serine 92 as New Positive Regulators of Human Snail1 Function: Potential Involvement of Casein Kinase-2 and the cAMP-activated Kinase Protein Kinase A

MacPherson, M. R., Molina, P., Souchelnytskyi, S., Wernstedt, C., Martı́n-Pérez, J., Portillo, F., & Cano, A. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0504 · Cited by 74 · see citing works

Cyclic AMP sensor EPAC proteins and energy homeostasis

Almahariq, M. F., Mei, F. C., & Cheng, X. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.10.004 · Cited by 70 · see citing works

Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis

Greuter, T., Malhi, H., Gores, G. J., & Shah, V. H. (2017) · JCI Insight · doi:10.1172/jci.insight.95354 · Cited by 67 · see citing works

Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95

Reinehr, R., & Häussinger, D. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.044 · Cited by 63 · see citing works

The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis

Zhou, M., Mok, M. T. S., Sun, H., Chan, A. W. H., Huang, Y., Cheng, A. S. L., & Xu, G. (2017) · Oncogene · doi:10.1038/onc.2017.38 · Cited by 62 · see citing works

Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells

Desmoulière, A., Xu, G., Monte‐Alto‐Costa, A., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80192-5 · Cited by 61 · see citing works

2 PDE4 Inhibitors – A Review of the Current Field

Press, N. J., & Banner, K. H. (2009) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)00202-6 · Cited by 60 · see citing works

cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochromecrelease

Webster, C. R. L., Usechak, P., & Anwer, M. S. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00410.2001 · Cited by 60 · see citing works

Dysregulated Cytokine Metabolism, Altered Hepatic Methionine Metabolism and Proteasome Dysfunction in Alcoholic Liver Disease

McClain, C. J., Barve, S. S., Joshi‐Barve, S., Song, Z., Deaciuc, I. V., Chen, T., & Hill, D. B. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000189276.34230.f5 · Cited by 57 · see citing works

Innate immunity and cell death in alcoholic liver disease: Role of cytochrome P4502E1

Barnes, M. A., Roychowdhury, S., & Nagy, L. E. (2014) · Redox Biology · doi:10.1016/j.redox.2014.07.007 · Cited by 55 · see citing works

Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation

Chen, R., Williams, A. J., Liao, Z., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.033 · Cited by 54 · see citing works

Lack of Efficacy of an Inhibitor of PDE4 in Phase 1 and 2 Trials of Patients With Nonalcoholic Steatohepatitis

Ratziu, V., Bédossa, P., Francque, S., Larrey, D. G., Aithal, G. P., Serfaty, L., Voiculescu, M., Preoțescu, L., Nevens, F., de Lédinghen, V., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.040 · Cited by 54 · see citing works

Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis

Cullen, K. A., McCool, J., Anwer, M. S., & Webster, C. R. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00517.2003 · Cited by 53 · see citing works

Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy

Vetrugno, M., Uva, M. G., Russo, V., et al. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0021 · Cited by 52 · see citing works

pH sensing via bicarbonate-regulated “soluble” adenylyl cyclase (sAC)

Rahman, N., Buck, J., & Levin, L. R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00343 · Cited by 51 · see citing works

Phosphodiesterase‐4 inhibition as a therapeutic strategy for metabolic disorders

Wu, C., & Rajagopalan, S. (2016) · Obesity Reviews · doi:10.1111/obr.12385 · Cited by 49 · see citing works

Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol‐induced steatosis

Avila, D. V., Barker, D. F., Zhang, J., McClain, C. J., Barve, S. S., & Gobejishvili, L. (2016) · The Journal of Pathology · doi:10.1002/path.4760 · Cited by 49 · see citing works

Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B

Hodge, A. D., Lim, S., Goh, E., Wong, O., Marsh, P. J., Knight, V., Sievert, W., & de Courten, B. V. (2017) · Nutrients · doi:10.3390/nu9010056 · Cited by 49 · see citing works

Pentoxifylline for the treatment of nonalcoholic fatty liver disease

Zeng, T., Zhang, C., Zhao, X., & Xie, K.-Q. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000068 · Cited by 48 · see citing works

Antidiabetic Sulfonylureas and cAMP Cooperatively Activate Epac2A

Takahashi, T., Shibasaki, T., Takahashi, H., Sugawara, K., Ono, A., Inoue, N., Furuya, T., & Seino, S. (2013) · Science Signaling · doi:10.1126/scisignal.2004581 · Cited by 48 · see citing works

Differential Modulation of CYP2E1 Activity by cAMP-Dependent Protein Kinase upon Ser129Replacement

Oesch‐Bartlomowicz, B., Padma, P. R., Becker, R., Richter, B., Hengstler, J. G., Freeman, J. E., Wolf, C. R., & Oesch, F. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4120 · Cited by 48 · see citing works

The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism

Möllmann, J., Kahles, F., Lebherz, C., Kappel, B. A., Baeck, C., Tacke, F., Werner, C., Federici, M., Marx, N., & Lehrke, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12839 · Cited by 48 · see citing works

Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice

Feng, H.-F., Chen, J., Wang, H., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.59 · Cited by 48 · see citing works

Increase in Cellular Cyclic AMP Concentrations Reverses the Profibrogenic Phenotype of Cardiac Myofibroblasts: A Novel Therapeutic Approach for Cardiac Fibrosis

Lu, D., Aroonsakool, N., Yokoyama, U., Patel, H. H., & Insel, P. A. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087742 · Cited by 47 · see citing works

Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis

Wang, H., Zhao, M., Sud, N., Christian, P., Shen, J., Song, Y., Pashaj, A., Zhang, K., Carr, T. P., & Su, Q. (2016) · Scientific Reports · doi:10.1038/srep32246 · Cited by 47 · see citing works

Rolipram Attenuates Bile Duct Ligation–Induced Liver Injury in Rats: A Potential Pathogenic Role of PDE4

Gobejishvili, L., Barve, S. S., Breitkopf‐Heinlein, K., Li, Y., Zhang, J., Avila, D. V., Dooley, S., & McClain, C. J. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204933 · Cited by 46 · see citing works

Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice

Fischer, W., Schudt, C., & Wendel, A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90219-m · Cited by 45 · see citing works

Phosphodiesterase 4 Inhibition as a Potential New Therapeutic Target in Obese Women With Polycystic Ovary Syndrome

Jensterle, M., Kocjan, T., & Janež, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1430 · Cited by 44 · see citing works

The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis.

Pilkis, S. J., Claus, T. H., & El‐Maghrabi, M. R. (1988) · PubMed · Cited by 43 · see citing works

Suppression of Tumor Necrosis Factor α Production by cAMP in Human Monocytes: Dissociation with mRNA Level and Independent of Interleukin-10

Shames, B. D., McIntyre, R. C., Bensard, D. D., et al. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6178 · Cited by 42 · see citing works

Activators of PKA and Epac Distinctly Influence Insulin Secretion and Cytosolic Ca2+ in Female Mouse Islets Stimulated by Glucose and Tolbutamide

Henquin, J.-C., & Nenquin, M. (2014) · Endocrinology · doi:10.1210/en.2014-1247 · Cited by 41 · see citing works

Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies

Iredale, J. P., Pellicoro, A., & Fallowfield, J. A. (2017) · Digestive Diseases · doi:10.1159/000456581 · Cited by 40 · see citing works

New paradigms in cAMP signalling

Antoni, F. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.034 · Cited by 39 · see citing works

Fibrogenesis in alcoholic liver disease

Fujii, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i25.8048 · Cited by 37 · see citing works

Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease

Ceccarelli, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16443 · Cited by 35 · see citing works

Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival

Massimi, M., Cardarelli, S., Galli, F., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25798 · Cited by 35 · see citing works

Role of CYP2E1 in the pathogenesis of alcoholic liver disease:modifications by cAMP and Ubiquitin-proteasome pathway (update October 1999)

Gouillon, Z. ‐. (1999) · Frontiers in bioscience · doi:10.2741/gouillon · Cited by 34 · see citing works

Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP

Kawada, N., Kuroki, T., Kobayashi, K., Inoue, M., & Kaneda, K. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02091547 · Cited by 33 · see citing works

Epac2: a sulfonylurea receptor?

Rehmann, H. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110640 · Cited by 33 · see citing works

The TLR4‐IRE1α pathway activation contributes to palmitate‐elicited lipotoxicity in hepatocytes

Shen, C., Ma, W., Ding, L., Li, S.-T., Dou, X., & Song, Z.-Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13636 · Cited by 33 · see citing works

Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study

Fang, C.-L., Wen, C.-J., Aljuffali, I. A., Sung, C. T., Huang, C.-L., & Fang, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.038 · Cited by 32 · see citing works

Ecklonia cava Polyphenol Has a Protective Effect against Ethanol-Induced Liver Injury in a Cyclic AMP-Dependent Manner

Yamashita, H., Goto, M., Matsui‐Yuasa, I., et al. (2015) · Marine Drugs · doi:10.3390/md13063877 · Cited by 31 · see citing works

14-Deoxyandrographolide targets adenylate cyclase and prevents ethanol-induced liver injury through constitutive NOS dependent reduced redox signaling in rats

Mandal, S., Nelson, V. K., Mukhopadhyay, S., Bandhopadhyay, S., Maganti, L., Ghoshal, N., Sen, G., & Biswas, T. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.05.056 · Cited by 30 · see citing works

EPAC activation inhibits acetaldehyde-induced activation and proliferation of hepatic stellate cell via Rap1

Yang, Y., Yang, F., Wu, X., Lv, X., & Li, J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0437 · Cited by 30 · see citing works

Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis

Taguchi, I., Oka, K., Kitamura, K., et al. (1999) · Inflammation Research · doi:10.1007/s000110050475 · Cited by 28 · see citing works

Popeye domain-containing proteins and stress-mediated modulation of cardiac pacemaking

Simrick, S., Schindler, R. F. R., Poon, K., et al. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.02.002 · Cited by 27 · see citing works

Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats

Kawy, H. S. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.044 · Cited by 26 · see citing works

Pentoxifylline prevents pig serum‐induced rat liver fibrosis by inhibiting interleukin‐6 production

Toda, K., Kumagai, N., Kaneko, F., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05749.x · Cited by 26 · see citing works

Forskolin Compared with Beclomethasone for Prevention of Asthma Attacks: A Single-Blind Clinical Trial

Huerta, M., Urzúa, Z., Trujillo, X., et al. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800229 · Cited by 26 · see citing works

The Proximal Promoter Region Is Essential for Lipopolysaccharide Induction and Cyclic AMP Inhibition of Mouse Tumor Necrosis Factor- α

O'Donnell, P. M., & Taffet, S. M. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900252982016 · Cited by 25 · see citing works

Free Fatty Acids Shift Insulin-induced Hepatocyte Proliferation towards CD95-dependent Apoptosis

Sommerfeld, A., Reinehr, R., & Häussinger, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617035 · Cited by 24 · see citing works

Release of Tumor Necrosis Factor-α from Coronary Smooth Muscle: Activation of NF-κB and Inhibition by Elevated Cyclic AMP

Newman, W. H., Zhang, L.-M., Lee, D. H., et al. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5456 · Cited by 23 · see citing works

Phosphorylation and activation of acetyl-coenzyme A carboxylase kinase by the catalytic subunit of cyclic AMP-dependent protein kinase

Lent, B. A., & Kim, K.-H. (1983) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(83)90113-3 · Cited by 22 · see citing works

Pentoxifylline Attenuates Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis by Suppressing TNF-αExpression and Endoplasmic Reticulum Stress

Chae, M. K., Park, S. G., Song, S. O., Kang, E. S., Soo, B., Lee, H. C., & Lee, B. (2012) · Experimental Diabetes Research · doi:10.1155/2012/762565 · Cited by 22 · see citing works

cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinase

Johnston, A. N., Ponzetti, K. M., Anwer, M. S., & Webster, C. R. L. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2010 · Cited by 22 · see citing works

Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin E2 in Liver Fibrosis Is Associated with Reduced Fibrogenesis

Schippers, M., Beljaars, L., Post, E., Lotersztajn, S., Reker‐Smit, C., Han, B., Muñoz-LLancao, P., Schmidt, M., & Poelstra, K. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241646 · Cited by 22 · see citing works

Inhibitors of phosphodiesterases in the treatment of cough

Mokrý, J., Urbanová, A., Kertys, M., et al. (2018) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2018.01.008 · Cited by 22 · see citing works

cAMP prevents TNF-induced apoptosis through inhibiting DISC complex formation in rat hepatocytes

Bhattacharjee, R., Xiang, W., Wang, Y., Zhang, X., & Billiar, T. R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.087 · Cited by 21 · see citing works

Pentoxifylline downregulates α (I) collagen expression by the inhibition of Iκbα degradation in liver stellate cells

Hernández, E., Bucio, L., Souza, V., Escobar, M., Gómez-Quiroz, L. E., Farfan, B., Kershenobich, D., & Gutiérrez‐Ruíz, M. C. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-9039-5 · Cited by 20 · see citing works

Randomized Prospective Trial of Gentian Violet with Dibutyryl cAMP and Povidone-iodine with Surgar as Treatment for Pressure Sores Infected with Methicillin-resistant Staphylococcus aureus in Elderly Patients.

Toba, K., Sudoh, N., Nagano, K., et al. (1997) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.34.577 · Cited by 19 · see citing works

Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge

Aroor, A. R., Jackson, D. E., & Shukla, S. D. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.045 · Cited by 18 · see citing works

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy).

Movassaghi, S., Sharifi, Z. N., Mohammadzadeh, F., et al. (2013) · PubMed · Cited by 17 · see citing works

A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis

Yalçın, M., Akarsu, M., Çelik, A., Sağol, Ö., Tunalı, S., ERTENER, Ö., Bengı, G., & Akpınar, H. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.5121 · Cited by 17 · see citing works

Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease

Gobejishvili, L., Ghare, S. S., Khan, R., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.09.008 · Cited by 16 · see citing works

Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.

Im, G. Y., & Lucey, M. R. (2016) · PubMed Central · Cited by 15 · see citing works

Regulation of Rat Alcohol-Dehydrogenase by Cyclic AMP in Primary Hepatocyte Culture

Potter, J. J., MacDougald, O. A., & Mezey, E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1402 · Cited by 13 · see citing works

Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway

Li, H., Hua, J., Guo, C., Wang, W., Wang, B., Yang, D., Wei, P., & Lu, Y. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1594-7 · Cited by 13 · see citing works

Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide‐induced liver injury in rats

Matsuhashi, T., Otaka, M., Odashima, M., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03512.x · Cited by 12 · see citing works

S-adenosylmethionine and cAMP confer differential cytoprotection against bile acid-induced apoptosis in canine renal tubular cells and primary rat hepatocytes.

Webster, C. R. L., Boria, P. A., Usechak, P., & Anwer, M. S. (2002) · PubMed · Cited by 12 · see citing works

The effect of glucagon and cyclic adenosine monophosphate on acute liver damage induced by acetaminophen.

Kelava, T., Ćavar, I., Vukojević, K., et al. (2013) · PubMed · doi:10.14670/hh-28.245 · Cited by 9 · see citing works

Pentoxifylline inhibits hepatic stellate cells proliferation via the R af/ ERK pathway

Zhang, D., Jiang, H., Wang, Y., et al. (2012) · Apmis · doi:10.1111/j.1600-0463.2011.02868.x · Cited by 8 · see citing works

Cardiovascular effects of colforsin daropate hydrochloride, a novel drug for the treatment of acute heart failure.

Hosono, M. (1999) · Folia Pharmacologica Japonica · doi:10.1254/fpj.114.83 · Cited by 8 · see citing works

The effect of thymic humoral factor on intracellular lymphocyte cyclic AMP in alcoholic liver disease.

Barlas, N., Mutchnick, M. G., Grant, G., et al. (1983) · PubMed · Cited by 8 · see citing works

The stable cyclic adenosine monophosphate analogue, dibutyryl cyclo-adenosine monophosphate (bucladesine), is active in a model of acute skin inflammation

Rundfeldt, C., Steckel, H., Sörensen, T. C., & Właź, P. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1216-6 · Cited by 6 · see citing works

Comparative Hemodynamic Effects of Intravenous Dobutamine and Dibutyryl Cyclic AMP, a New Inotropic Agent, in Severe Congestive Heart Failure

Miyagi, Y., Sasayama, S., Nakajima, H., et al. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199001000-00022 · Cited by 6 · see citing works

Effect of adenosine 3',5'-cyclic monophosphate derivatives on acute liver injury induced by carbon tetrachloride.

Saito, M., Ayako, N. A. S. U., Kataoka, S., et al. (1992) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.15.449 · Cited by 3 · see citing works

Cell-cell communication: New insights and clinical implications

Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433 · see citing works

Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease

Raya Tonetti, F., Eguileor, A., Mrdjen, M., Pathak, V., Travers, J., Nagy, L. E., & Llorente, C. (2024) · Hepatology · doi:10.1097/hep.0000000000000924 · Cited by 78 · see citing works

Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis

Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Effects of saterinone and its enantiomers R(+)-saterinone and S(−)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts

Zimmermann, W., Scholz, H., Schumacher, C., et al. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01258467 · Cited by 14 · see citing works

The Phosphodiesterases in the Rat Pancreas

van Venrooij, W. J. W., & POORT, C. (1970) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1970.tb00941.x · Cited by 6 · see citing works

Characterization of inhibitors of phosphodiesterase 1C on a human cellular system

Dunkern, T. R., & Hatzelmann, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06001.x · Cited by 36 · see citing works

Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases

Morishima, I. (1975) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(75)90013-3 · Cited by 10 · see citing works